Phillip Allen Sharp - Cancer Science

Author Information

Phillip Allen Sharp is a prominent researcher affiliated with the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, MA, USA. His research primarily focuses on cancer biology, with particular expertise in the mechanisms of gene expression and RNA biology. Sharp's work has significantly contributed to our understanding of the molecular underpinnings of cancer and the development of innovative therapeutic strategies.

Research Contributions

Phillip Allen Sharp has made substantial contributions to the field of cancer research, particularly in understanding the role of RNA and transcriptional condensates in gene regulation. His recent work involves exploring how engineered CRISPR-Cas9 nucleases alter DNA repair pathways and the interaction of cancer therapeutics within nuclear condensates. Sharp has also conducted pioneering research on microRNAs and their impact on stem cell states and neuronal gene programs. His studies provide critical insights into the cellular and molecular processes that drive cancer progression and therapeutic resistance.

Aliases

Phillip Allen Sharp is also known by various aliases, including Phillip Sharp, P A Sharp, Phillip A. Sharp, and P. Sharp, among others. These variations are commonly encountered in academic publications and databases.

Publication and Citation Metrics

Metric Value
Total Citations 94,170
H-index 149
Total Publications 508

Publications:

DOI: 10.1101/2022.03.10.483793

Year: 2022

DOI: 10.1200/JCO.2021.39.15_SUPPL.3131

Year: 2021

DOI: 10.1158/1538-7445.SABCS20-GS3-10

Year: 2021

DOI: 10.1261/rna.078997.121

Year: 2021

DOI: 10.1016/j.cell.2020.11.030

Year: 2021

DOI: 10.1073/pnas.1920695117

Year: 2020

DOI: 10.1126/science.aaz4427

Year: 2020

DOI: 10.1016/j.molcel.2020.01.020

Year: 2020

DOI: 10.1016/j.molcel.2019.07.009

Year: 2019

DOI: 10.1101/717868

Year: 2019

Top Searches
Brain Tumor Breast cancer cancer Cancer Diagnostics Cancer Genomics Chemotherapy Essential Thrombocythemia hepatocellular carcinoma Lung Cancer Molecular Biomarkers Nanotechnology Non-Hodgkin’s Lymphoma Radiation-Induced Malignancies
Frequently asked queries:
When should a patient seek a specialist consultation?
Why is a Total Colectomy Performed?
How Can Gratitude Journaling Help During Cancer Treatment?
What is Serology?
Why is Carcinogen Classification Important?
Are There Long-Term Benefits of Immunotherapy?
Can Medication Schedules Be Adjusted?
Why is Plagiarism Detection Important in Cancer Research?
How Do Biotechnology Firms Contribute to Cancer Diagnostics?
How does cancer treatment impact a patient's immune system?
Follow Us

Partnered Content Networks

Relevant Topics